Decreased arachidonic acid liberation participates in the anti-aggregatory effect of the histamine H1-receptor antagonist Bromadryl

Platelets

Volumn 10, Issue 6, 1999, Pages 391-398

  Jančinová, Viera ^a   Nosál, Rado ^a   Danihelová, Edita ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b Inst Haematol/Transfusiology   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ARACHIDONIC ACID; EMBRAMINE; HISTAMINE RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE A2; PROTEIN KINASE C; THROMBIN; THROMBOXANE;

ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; MEMBRANE STRUCTURE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION;

EID: 0033428371     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109975861     Document Type: Article

References (35)

1. 1. Kodavanti U P, Mehendale H M. Cationic amphiphilic drugs and phospholipid storage disorder. Pharmacol Rev 1990; 42: 327-54.
2. 2. Nosál' R, Jančinová V, Ondriaš K, Jakubovský J, Balgavý P. The interaction of β-adrenoceptor blocking drugs with platelet aggregation, calcium displacement and fluidization of the membrane. Biochim Biophys Acta 1985; 821: 217-28.
3. 3. Girke S, Mohr K, Schrape S. Comparison between the activities of cationic amphiphilic drugs to affect phospholipid membranes and to depress cardiac function. Biochem Pharmacol 1989; 38: 2487-96.
4. 4. Dash D, Rao K. Effect of propranolol on platelet signal transduction. Biochem J 1995; 309: 99-104.
5. 5. Sozzani S, Agwu D E, McCall C E, O'Flaherty J T, Schmitt J D, Kent J D, McPhail L C. Propranolol, a phosphatidate phosphohydrolase inhibitor, also inhibits protein kinase C. J Biol them 1992; 267: 20481-8.
6. 6. McCrea J M, Robinson P, Gerrard J M. Mepacrine (quinacrine) inhibition of thrombin-induced platelet responses can be overcome by lysophosphatidic acid. Biochim Biophys Acta 1985; 842: 189-94.
7. 2 activation. Arch Biochem Biophys 1991; 289: 47-52.
8. 8. Jančinová V, Nosál' R. Differences among betaadrenoceptor blocking drugs in modifying platelet aggregation and arachidonic acid liberation under thrombin stimulation. Thromb Res 1989; 54: 687-98.
9. 9. Nosál' R, Jančinová V, Petríková M. Involvement of arachidonic acid and its metabolites in the inhibitory effect of beta-adrenoceptor blocking drugs on blood platelets. In: Sinzinger H, Schror K, eds, Prostaglandins in the Cardiovascular System. Basel: Birhäuser Verlag, 1992: 47-52.
10. 10. Nosál' R, Petríková M, Jančinová V. Alterations in lipid peroxidation of thrombin stimulated rat platelets treated with β-adrenoceptor blocking drugs. J Lipid Mediat 1993; 8: 121-32.
11. 11. Nosál' R, Jančinová V, Petríková M. Chloroquine inhibits stimulated platelets at the arachidonic acid pathway. Thromb Res 1995; 77: 531-42.
12. 1-histamine antagonist dithiaden inhibits human platelet function in vitro. Platelets 1997; 8: 175-80.
13. 13. Ko F N, Sheu S J, Liu Y M, Huang T F, Teng C M. Inhibition of rabbit platelet aggregation by 1,4-naphtoquinones. Thromb Res 1990; 57: 453-63.
14. 14. Shams G, Romstedt K J, Lust L A, Clark M T, Miller D D, Feller D R. Beta-adrenergic receptor and platelet inhibitory activities of a new series of trimetoquinol and related benzazepine analogs. Gen Pharmacol 1997; 28: 323-30.
15. 15. Jančinová V, Nosál' R, Petríková M. On the inhibitory effect of chloroquine on blood platelet aggregation. Thromb Res 1994; 74: 495-504.
16. 16. Chong B H, Kaplin I J. Effect of quinidine on platelets. Haemostasis 1990; 20: 106-11.
17. 17. Shah B H, Nawaz Z, Virani S S, Ali I Q, Saeed S A, Gilani A H. The inhibitory effect of cinchonine on human platelet aggregation due to blockade of calcium influx. Biochem Pharmacol 1998; 56: 955-60.
18. 18. Kanaho Y, Kometani M, Sato T, Fujii T. Mechanism of inhibitory effect of some amphiphilic drugs on platelet aggregation induced by collagen, thrombin or arachidonic acid. Thromb Res 1983; 31: 817-31.
19. 19. Nosál' R, Jančinová V, Petríková M. Antihistaminic drug bromadryl and stimulated platelet aggregation. Agents Actions 1994; 41: C104-5.
20. 20. Jančinová V, Petríková M, Ujházy E, Nosál' R. Effect of the antihistaminic drug Bromadryl on ex vivo platelet functions during gestation in rats. Agents Actions 1994; 41: C101-3.
21. 21. Jančinová V, Nosál' R, Danihelová E. On the effect of the antihistaminic drug bromadryl on human platelets in vitro. Inflamm Res 1996; 45: S21-2.
22. 22. Blockmans D, Deckmyn H, Vermylen J. Platelet activation. Blood Rev 1995; 9: 143-56.
23. 23. Herbette L, Katz A M, Sturtevant J M. Comparisons of the interaction of propranolol and timolol with model and biological membrane systems. Mol Pharmacol 1983; 24: 259-69.
24. 24. Dash D, Rao G R. Characterization of the effects of propranolol on the physical state of platelet membrane. Arch Biochem Biophys 1990; 276: 343-7.
25. 25. Koner B C, Jain M, Dash D. Platelets from eclampsia patients have reduced membrane microviscosity and lower activities of the signalling enzymes. Int J Biochem Cell Biol 1998; 30: 147-54.
26. 26. Jančinová V, Májeková M, Nosál' R, Petríková M. Inhibition of blood platelet functions by cationic amphiphilic drugs in relation to their physico-chemical properties. Blood Coag Fibrinol 1996; 7: 191-3.
27. 27. Jančinová V, Nosál' R. Cimetidine and ketotifen inhibit stimulated aggregation and histamine liberation from rabbit blood platelets. Agents Actions 1989; 27: 135-7.
28. 28. Nosál' R. Blood platelets and chloroquine. Platelets 1995; 6: 310-6.
29. 29. Yang X, Gabbeta J, Rao A K. Platelet activation with combination of ionophore A23187 and a direct protein kinase C activator induces normal secretion in patients with impaired receptor mediated secretion and abnormal signal transduction. Thromb Res 1997; 88: 317-28.
30. 30. Mahadevappa V G, Sicilia F. Mobilization of arachidonic acid in thrombin-stimulaled human platelets. Biochem Cell Biol 1990; 68: 520-7.
31. 2 synthesis in canine whole blood. Feder Proc 1983; 42: 640-5.
32. 32. Gerrard J M, Saxena S P, McNicol A. Histamine as an intracellular messenger in human platelets. Adv Exp Med Biol 1993; 344: 209-19.
33. 2+-ionophore A23187-activated human blood platelets. Platelets 1998; 9: 203-6.
34. 34. Barradas M A, Mikhailidis D P. Serotonin, histamine and platelets in vascular disease with special reference to peripheral vascular disease. Braz J Med Biol Res 1992; 25; 1063-76.
35. 35. Mosior M, Newton A C. Mechanism of interaction of protein kinase C with phorbol esters. Reversibility and nature of membrane association. J Biol Chem 1995; 270: 25526-33.